Oligonucleotide Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Oligonucleotide Therapeutics Market estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2028, growing at a CAGR of 8% during the forecast period 2022-2028.

Oligonucleotides are short-stranded DNA or RNA, usually made using automated synthesizers. In addition, purification of oligonucleotides is accomplished by anion exchange chromatography, followed by freezing and desalting techniques. In addition, the synthesis of siRNA duplex oligonucleotides is achieved through an annealing step that brings the two purified oligonucleotide strands closer together in equimolar ratio. There are many differences between oligonucleotide therapeutics and conventional drugs. Oligonucleotide therapeutics can inhibit the expression of certain genes. This factor leads to the development of new oligonucleotides that target specific genes and treat chronic diseases. Chemically modified artificial nucleic acids are being utilized to develop these novel oligonucleotide therapeutics. The developed artificial oligonucleotide has further improved affinity for target mRNA and stability in vivo. These factors are likely to act as a growth factor for the global oligonucleotide therapeutics market.

Market Segments

On the basis of type

• Antisense
• Ribozymes
• Aptamers
• miRNA
• CpG/Immunostimulatory
• RNAi

On the basis of application

• Infectious diseases
• Oncology
• Neurodegenerative disorders
• Cardiovascular diseases
• Kidney diseases

Key Players

• miRagen Therapeutics, Inc.
• Ionis Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Gilead Sciences, Inc.
• Biogen Inc.
• Regulus Therapeutics Inc.

Scope of the Report

The research study analyzes the global Oligonucleotide Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Oligonucleotide Therapeutics Market Report

1. What was the Oligonucleotide Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Oligonucleotide Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Oligonucleotide Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.